4//SEC Filing
Knowles Julius 4
Accession 0001209191-22-034048
CIK 0001664710other
Filed
Jun 2, 8:00 PM ET
Accepted
Jun 3, 4:28 PM ET
Size
5.6 KB
Accession
0001209191-22-034048
Insider Transaction Report
Form 4
Knowles Julius
Director
Transactions
- Award
Stock Options (right to buy)
2022-06-01+8,293→ 8,293 totalExercise: $32.95Exp: 2032-05-31→ Common Stock (8,293 underlying)
Footnotes (1)
- [F1]The option shall vest in equal quarterly installments over the 12 months following the date of grant, provided that the grant will in any case be fully vested on the date of Issuer's 2023 annual meeting of stockholders, subject to the Reporting Person continuing to provide service through each such date.
Documents
Issuer
Keros Therapeutics, Inc.
CIK 0001664710
Entity typeother
Related Parties
1- filerCIK 0001808365
Filing Metadata
- Form type
- 4
- Filed
- Jun 2, 8:00 PM ET
- Accepted
- Jun 3, 4:28 PM ET
- Size
- 5.6 KB